Coral Laboratories Limited (BOM:524506)
613.00
+5.65 (0.93%)
At close: Jun 6, 2025
Coral Laboratories Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 798.67 | 20.71 | 61.3 | 25.06 | 23.25 | Upgrade
|
Short-Term Investments | 275.42 | 13.23 | 12.39 | 21.19 | 0.96 | Upgrade
|
Trading Asset Securities | - | 243.92 | 226.41 | 196.4 | 189.86 | Upgrade
|
Cash & Short-Term Investments | 1,074 | 277.87 | 300.1 | 242.65 | 214.07 | Upgrade
|
Cash Growth | 286.55% | -7.41% | 23.67% | 13.35% | 1825.58% | Upgrade
|
Accounts Receivable | 336.42 | 281.93 | 234.21 | 381.14 | 391.6 | Upgrade
|
Other Receivables | - | - | - | 0.06 | 0.05 | Upgrade
|
Receivables | 338.76 | 283.88 | 236.23 | 382.74 | 398.24 | Upgrade
|
Inventory | 98.71 | 151.57 | 125.04 | 183.62 | 216.75 | Upgrade
|
Prepaid Expenses | - | 0.87 | 0.86 | 1.97 | 1.19 | Upgrade
|
Other Current Assets | 253.89 | 824.36 | 573.17 | 497.06 | 455.97 | Upgrade
|
Total Current Assets | 1,765 | 1,539 | 1,235 | 1,308 | 1,286 | Upgrade
|
Property, Plant & Equipment | 242.26 | 232.74 | 242.82 | 244.94 | 209.08 | Upgrade
|
Long-Term Investments | 248.02 | 240.35 | 174.09 | 244.25 | 140.96 | Upgrade
|
Other Intangible Assets | 0.67 | 0.63 | 0.18 | 0.19 | 0.25 | Upgrade
|
Other Long-Term Assets | 34.74 | 41.04 | 87.46 | 98.04 | 35.4 | Upgrade
|
Total Assets | 2,295 | 2,057 | 1,743 | 1,899 | 1,675 | Upgrade
|
Accounts Payable | 27.16 | 132.4 | 42.12 | 87.98 | 147.75 | Upgrade
|
Accrued Expenses | 17.01 | 13.66 | 18.72 | 13.65 | 10.87 | Upgrade
|
Short-Term Debt | 35.59 | - | - | 60.39 | 62.54 | Upgrade
|
Current Income Taxes Payable | 83.3 | 49.09 | 18.2 | 27.5 | 25.82 | Upgrade
|
Other Current Liabilities | 86.52 | 53.84 | 39.57 | 65.66 | 28.66 | Upgrade
|
Total Current Liabilities | 249.58 | 248.99 | 118.6 | 255.18 | 275.65 | Upgrade
|
Long-Term Deferred Tax Liabilities | 25.54 | 25.7 | 25.36 | 25.75 | 25.15 | Upgrade
|
Other Long-Term Liabilities | 7.47 | 3.34 | 48.05 | 54.06 | 4.5 | Upgrade
|
Total Liabilities | 282.59 | 281.84 | 195.47 | 338.43 | 308.96 | Upgrade
|
Common Stock | 35.73 | 35.73 | 35.73 | 35.73 | 35.73 | Upgrade
|
Retained Earnings | - | 1,517 | 1,359 | 1,294 | 1,204 | Upgrade
|
Comprehensive Income & Other | 1,976 | 222.57 | 153.48 | 230.48 | 126.84 | Upgrade
|
Shareholders' Equity | 2,012 | 1,775 | 1,548 | 1,561 | 1,366 | Upgrade
|
Total Liabilities & Equity | 2,295 | 2,057 | 1,743 | 1,899 | 1,675 | Upgrade
|
Total Debt | 35.59 | - | - | 60.39 | 62.54 | Upgrade
|
Net Cash (Debt) | 1,039 | 277.87 | 300.1 | 182.26 | 151.53 | Upgrade
|
Net Cash Growth | 273.74% | -7.41% | 64.66% | 20.28% | - | Upgrade
|
Net Cash Per Share | 290.67 | 77.78 | 84.00 | 51.02 | 42.41 | Upgrade
|
Filing Date Shares Outstanding | 3.57 | 3.57 | 3.57 | 3.57 | 3.57 | Upgrade
|
Total Common Shares Outstanding | 3.57 | 3.57 | 3.57 | 3.57 | 3.57 | Upgrade
|
Working Capital | 1,516 | 1,290 | 1,117 | 1,053 | 1,011 | Upgrade
|
Book Value Per Share | 562.96 | 496.83 | 433.29 | 436.81 | 382.48 | Upgrade
|
Tangible Book Value | 2,011 | 1,774 | 1,548 | 1,560 | 1,366 | Upgrade
|
Tangible Book Value Per Share | 562.77 | 496.65 | 433.24 | 436.75 | 382.40 | Upgrade
|
Buildings | - | 136.22 | 135.97 | 123.22 | 122.67 | Upgrade
|
Machinery | - | 362.81 | 355.02 | 331.99 | 289.31 | Upgrade
|
Construction In Progress | - | - | - | 17.22 | 5.02 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.